Rifampin affects polymorphonuclear leukocyte interactions with bacterial and synthetic chemotaxins but not interactions with serum-derived chemotaxins.

Three independent experimental approaches support the hypothesis that rifampin competes for receptors on polymorphonuclear leukocytes (PMLs) with small peptide chemoattractants, e.g., N-formylmethionylleucylphenylalanine (FMLP), but not with serum-derived chemoattractants (C5a). First, rifampin inhi...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Gray, G D, Smith, C W, Hollers, J C, Chenoweth, D E, Fiegel, V D, Nelson, R D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1983
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185941/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6318656/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.5.777
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!